The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Mozambique currently stands at 93%, which is 4% (4.5%) higher than 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Mozambique
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Mozambique
PMTCT antiretroviral therapy coverage
More indicators for Mozambique
Mozambique PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 93% | +4% |
| 2021 | 89% | +5% |
| 2020 | 84% | -5% |
| 2019 | 89% | +2% |
| 2018 | 87% | +1% |
| 2017 | 86% | +8% |
| 2016 | 78% | -6% |
| 2015 | 84% | +1% |
| 2014 | 83% | +10% |
| 2013 | 73% | +4% |
| 2012 | 69% | +25% |
| 2011 | 44% | +23% |
| 2010 | 21% | -44% |
| 2009 | 65% | +18% |
| 2008 | 47% | -1% |
| 2007 | 48% | +33% |
| 2006 | 15% | +8% |
| 2005 | 7% | +3% |
| 2004 | 4% | +2% |
| 2003 | 2% | +2% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |